Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity

Title
Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity
Authors
Keywords
BCL-X, L, PROTAC, Apoptosis, Platelet, Degradation
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 192, Issue -, Pages 112186
Publisher
Elsevier BV
Online
2020-02-28
DOI
10.1016/j.ejmech.2020.112186

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now